Tarsus Pharmaceuticals, Inc. ( (TARS) ) has released its Q3 earnings. Here is a breakdown of the information Tarsus Pharmaceuticals, Inc.

Pharma-specific data on changing customer preferences Customer landscape and pharma field force touchpoints Ensuring field force engagements are customer-centric Providing relevant messaging to ...

The Purdue University Pharmacy is located in Room 118 of the Robert E. Heine Pharmacy Building — next to the Purdue University Student Health (PUSH) Center — so you don't ever need to leave campus.

States may be getting ready to crack down even harder on pharmacy benefit managers ... One NAIC panel, the Regulatory Framework Task Force, plans to hear a presentation on PBM transparency initiatives ...

Embark on a fulfilling pharmacy career with our Pharmacy Technician Training Program. Choose the 8-week or 16-week version to gain the skills required for safe patient care. Successful course ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...

A good imagination and persistence are required. Medicinal and pharmaceutical chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the ...

The program partners with UpScriptHealth, Alto Pharmacy and Instacart to carry out its mission. Analogous to LillyDirect, patients can connect with a healthcare provider via a telehealth company ...

When the one pharmacy in town closed in Antwerp, a small community of about 1,600 in northwest Ohio, in September, it affected Candace Pidgeon in two ways. The pharmacy tech lost her job at the ...

Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

However, the new policy won’t make much of a dent in the price of pharmaceuticals. Drug companies, aware that restraints are coming, have already raised the prices for more than 350 highly ...

LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth $2.6 billion.